| 000 | 01380 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250518033349.0 | ||
| 264 | 0 | _c20210514 | |
| 008 | 202105s 0 0 eng d | ||
| 022 | _a1365-2133 | ||
| 024 | 7 |
_a10.1111/bjd.17991 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAugustin, M | |
| 245 | 0 | 0 |
_aContinued treatment with secukinumab is associated with high retention or regain of response. _h[electronic resource] |
| 260 |
_bThe British journal of dermatology _c01 2020 |
||
| 300 |
_a67-75 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 | _aEtanercept |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPsoriasis _xdrug therapy |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aUstekinumab |
| 700 | 1 | _aThaci, D | |
| 700 | 1 | _aEyerich, K | |
| 700 | 1 | _aPinter, A | |
| 700 | 1 | _aRadtke, M | |
| 700 | 1 | _aLauffer, F | |
| 700 | 1 | _aMrowietz, U | |
| 700 | 1 | _aGerdes, S | |
| 700 | 1 | _aPariser, D | |
| 700 | 1 | _aLebwohl, M | |
| 700 | 1 | _aSieder, C | |
| 700 | 1 | _aMelzer, N | |
| 700 | 1 | _aReich, K | |
| 773 | 0 |
_tThe British journal of dermatology _gvol. 182 _gno. 1 _gp. 67-75 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/bjd.17991 _zAvailable from publisher's website |
| 999 |
_c29576600 _d29576600 |
||